Substance / Medication

Cefmetazole

Overview

Active Ingredient
cefmetazole
RxNorm CUI
2182

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Reducing infectious complications and healthcare costs in transrectal ultrasound-guided prostate biopsy with single-dose cefmetazole and levofloxacin.
Onishi Katsuhiro, Morioka Hiroshi, Nishida Kazuki et al. · Urol Oncol · 2025
PMID: 39934057Observational
Comparison of the effects of cefmetazole and meropenem on microbiome: A pilot study.
Hayakawa Kayoko, Saito Sho, Miyoshi-Akiyama Tohru et al. · J Infect Chemother · 2024
PMID: 38879077Observational
Risk factors for cefmetazole-non-susceptible bacteremia in acute cholangitis.
Onishi Katsuhiro, Morioka Hiroshi, Imaizumi Takahiro et al. · J Infect Chemother · 2024
PMID: 37981024Observational
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing.
Hayakawa Kayoko, Matsumura Yasufumi, Uemura Kohei et al. · Antimicrob Agents Chemother · 2023
PMID: 37702483ObservationalFull text (PMC)
Cefmetazole for extended-spectrum β-lactamase-producing Enterobacteriaceae in pediatric pyelonephritis.
Araki Kotaro, Fukuoka Kahoru, Higuchi Hiroshi et al. · Pediatr Int · 2019
PMID: 30908807Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cefmetazole (substance)
SNOMED CT
96059002
UMLS CUI
C0007550
RxNorm CUI
2182

Clinical Data

This intervention maps to 5 entities in the Ltrl knowledge graph.

5
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.